Ligand Pharmaceuticals Inc (LGND)
EBITDA Margin
113.86%
Quarterly · Period ending:
LGND EBITDA Margin
Latest reported113.86%period ending
Latest reported113.86%period ending
LGND Quarterly EBITDA Margin (-226.09% → 113.86%)
Quarterly ebitda margin
High-resolution chart · PNG
LGND ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 113.8571% | |
| -27.6401% | |
| 111.2929% | |
| 129.3995% | |
| 43.8785% | |
| -89.4337% | |
| -69.3497% | |
| 6.5545% | |
| -133.0789% | |
| 394.9674% | |
| 94.865% | |
| -10.746% | |
| 49.1163% | |
| 148.5777% | |
| 244.9251% | |
| 44.2259% | |
| 47.3806% | |
| 18.5645% | |
| 9.7733% | |
| 37.8175% | |
| 28.2622% | |
| 44.7652% | |
| 32.256% | |
| -1.8997% | |
| 93.0806% | |
| -46.7025% | |
| 84.0462% | |
| -9.4083% | |
| -8.5765% | |
| 1,970.1614% | |
| -55.9641% | |
| 210.5665% | |
| 81.2789% | |
| 108.9713% | |
| 74.4551% | |
| 52.7311% | |
| 50.8162% | |
| 45.0849% | |
| 58.9027% | |
| 38.8547% | |
| 34.7421% | |
| 59.6027% | |
| 56.3279% | |
| 54.1551% | |
| 28.3907% | |
| 28.9138% | |
| 47.2128% | |
| 29.2193% | |
| 20.3903% | |
| 37.4232% | |
| 49.413% | |
| 30.4883% | |
| 28.2568% | |
| 40.2626% | |
| 38.8486% | |
| -9.7725% | |
| -30.1289% | |
| -1.313% | |
| 57.2279% | |
| -59.2057% | |
| -6.2575% | |
| -56.9302% | |
| -103.0203% | |
| -200.91% | |
| -48.0815% | |
| -67.573% | |
| 7.4909% | |
| 23.5034% | |
| -48.2486% | |
| -68.3105% | |
| -566.8173% | |
| -103.7157% | |
| -117.2565% | |
| -244.1321% | |
| -133.0676% | |
| -151.9438% | |
| -952.3404% | |
| -11,969.7872% | |
| 22.2151% | |
| -49.8079% | |
| -27.7107% | |
| -18.8143% | |
| 8.3517% | |
| 0.371% | |
| -3.8931% | |
| -30.5827% | |
| -65.7256% | |
| -23.7105% | |
| -38.2501% | |
| -41.7158% | |
| 24.7049% | |
| -14.9059% | |
| -18.9865% | |
| -38.6455% | |
| -15.4046% | |
| -19.8449% | |
| -40.4675% | |
| -2.9052% | |
| -5.3703% | |
| -14.8587% |